Ikarian Capital »

Adlai Nortye Ltd Sponsored shares owned by Ikarian Capital

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $235k 34k 6.92

More positions owned by Ikarian Capital

Terns Pharmaceuticals (TERN)
Spdr Series Trust State Street Spd Put Option (XBI)
Cytokinetics Com New (CYTK)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Kodiak Sciences (KOD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Abivax Sa Sponsored Ads (ABVX)
Alumis (ALMS)
Bristol Myers Squibb Put Option (BMY)
Capricor Therapeutics Com New (CAPR)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Praxis Precision Medicines I Com New (PRAX)
Biosante Pharmaceuticals (ANIP)
Harrow Health (HROW)

View all positions for Ikarian Capital

Top funds holding Adlai Nortye Ltd Sponsored

VR Adviser
Cormorant Asset Management
Squadron Capital Management
Balyasny Asset Management
Millennium Management
Casdin Capital
Woodline Partners
UBS Group
Ameriprise Financial
ADAR1 Capital Management
Toroso Investments
Cantor Fitzgerald, L. P.
TD Asset Management
Ikarian Capital
Persistent Asset Partners

View all funds holding Adlai Nortye Ltd Sponsored